Inicio › Enfermedad de obstrucción pulmonar crónica › Oklahoma

Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Oklahoma

9 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Oklahoma.

Ciudades en Oklahoma

Texto oficial del estudio (inglés)

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Research Site, Oklahoma City
Research Site, Tulsa

ReclutandoFase 2

Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Layrek Clinical Research- Site Number : 8400066, Tulsa

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Layrek Clinical Research, Tulsa

ReclutandoFase 2/3

Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Epic Medical Research - Chickasha- Site Number : 8400097, Chickasha

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

Research Site, Oklahoma City
Research Site, Tulsa

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Research Site, Norman
Research Site, Oklahoma City
Research Site, Tulsa

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Research Site, Oklahoma City

ReclutandoFase 3

Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

GSK Investigational Site, Edmond

ReclutandoFase 3

Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Hightower Clinical, Oklahoma City

ReclutandoEstudio observacional

Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.